LILRB1 Protein (AA 223-410) (His tag)
-
- Antigène Voir toutes LILRB1 Protéines
- LILRB1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 223-410
-
Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Purification/Conjugué
- Cette LILRB1 protéine est marqué à la His tag.
- Application
- Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)
- Séquence
- Ser223-His410 (Accession # Q8NHL6)
- Attributs du produit
- Recombinant Leukocyte Immunoglobulin Like Receptor Subfamily B, Member 1 (LILRB1), Prokaryotic expression, Ser223-His410 (Accession # Q8NHL6), N-terminal His Tag
- Pureté
- > 95 %
- Top Product
- Discover our top product LILRB1 Protéine
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Isoelectric Point:7.8
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-80 °C
- Stockage commentaire
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- LILRB1 (Leukocyte Immunoglobulin-Like Receptor, Subfamily B (With TM and ITIM Domains), Member 1 (LILRB1))
- Autre désignation
- Leukocyte Immunoglobulin Like Receptor Subfamily B, Member 1 (LILRB1 Produits)
- Synonymes
- CD85J Protein, ILT-2 Protein, ILT2 Protein, LIR-1 Protein, LIR1 Protein, MIR-7 Protein, MIR7 Protein, leukocyte immunoglobulin like receptor B1 Protein, LILRB1 Protein
- Sujet
- CD85j, LILR-B1, ILT2, LIR1, MIR7, CD85 antigen-like family member J, Immunoglobulin-like transcript 2, Monocyte/macrophage immunoglobulin-like receptor 7
- UniProt
- Q8NHL6
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
-